Efficacy of cilostazol in canine bradyarrhythmia

Recently, cilostazol, a phosphodiesterase III inhibitor, has been described as alternative medical treatment for canine bradyarrhythmia in cases for which pacemaker implantation was not indicated or available. In this retrospective study, we investigated the use and efficacy of cilostazol in dogs wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmori, Takahiro, Matsumura, Yuri, Yoshimura, Aritada, Morita, Shohei, Hasegawa, Hiroshi, Hirao, Daiki, Fukushima, Ryuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427924/
https://www.ncbi.nlm.nih.gov/pubmed/36061105
http://dx.doi.org/10.3389/fvets.2022.954295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427924/
https://www.ncbi.nlm.nih.gov/pubmed/36061105
http://dx.doi.org/10.3389/fvets.2022.954295

Ejemplares similares